Hypertension, commonly known as high blood pressure, affects over 1.28 billion people worldwide, making it one of the most prevalent chronic health conditions. Despite advancements in medications and lifestyle interventions, many patients struggle to achieve optimal blood pressure control, particularly those with resistant hypertension. As researchers explore innovative approaches to managing this condition, gene therapy has emerged as a promising frontier. By targeting the genetic mechanisms underlying hypertension, gene-based therapies offer the potential for more precise and long-lasting treatment. This article examines the science behind gene therapy for hypertension, the experimental therapies under development, and the potential challenges and future prospects of this cutting-edge approach.
Tag Archives: RAAS Pathway
HEALING: MEDICAL AND HEALTH CONDITIONS
New Frontiers in Hypertension Drugs: Angiotensin Blockers and Beyond
Hypertension, a condition characterized by consistently high blood pressure, affects over a billion people worldwide and remains a leading cause of cardiovascular disease, kidney failure, and stroke. Despite significant progress in treatment, many patients fail to achieve optimal blood pressure control due to medication resistance, side effects, or limited therapeutic options. Recent advancements in hypertension drugs, including the development of angiotensin blockers and novel therapeutic approaches, are transforming the landscape of hypertension management. This article explores the evolution of pharmaceutical options for hypertension, highlighting recent innovations and their potential to improve outcomes.